Evofem Biosciences Announces Financial Results for the Third

1 day ago · Aditxt, Inc. (Nasdaq: ADTX) has invested $5.0 million in Evofem since May 2024, including $1.3 million from the sale of Series F-1 Preferred Stock to Aditxt in the third quarter …

CouponFollow Extension

$5
OFF

Evofem Biosciences Announces Financial Results For The Third

1 week from now

1 day ago · Aditxt, Inc. (Nasdaq: ADTX) has invested $5.0 million in Evofem since May 2024, including $1.3 million from the sale of Series F-1 Preferred Stock to Aditxt in the third quarter …

nasdaq.com

$5
OFF

Evofem Biosciences Announces Financial Results For The Third …

1 week from now

1 day ago · Aditxt, Inc. (Nasdaq: ADTX) has invested $5.0 million in Evofem since May 2024, including $1.3 million from the sale of Series F-1 Preferred Stock to Aditxt in the third quarter …

prnewswire.com

$2.37
OFF

Evofem Biosciences Reports Q3 2024 Financial Results

1 week from now

1 day ago · Evofem’s latest quarterly earnings report highlights a challenging financial period, with the company reporting a net loss of $2.37 million for the three months ended September 30, …

businessinsider.com

$5
OFF

Evofem Biosciences Announces Financial Results For The Third

1 week from now

Nov 14, 2023 · In This Story. EVFM. --Evofem Biosciences, Inc. today announced financial results for the third quarter and nine months ended September 30, 2023. $5.1 million in net product …

nasdaq.com

$5
OFF

Evofem Biosciences Announces Preliminary Results For The Third

1 week from now

Oct 24, 2023 · Phexxi net product sales expected to be $5.0 to $5.2 million for the third quarter of 2023. Evofem remains on track to deliver its third consecutive year of net product sales …

nasdaq.com

$0.02
OFF

Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial ...

1 week from now

Zeit Aktuelle Nachrichten; Do: Evofem Biosciences GAAP EPS of -$0.02, revenue of $4.49M: Do: Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third …

finanznachrichten.de

81%
OFF

Evofem Biosciences Announces Financial Results For The Third

1 week from now

Nov 14, 2023 · — Third consecutive quarter of favorable sales and marketing expense as a percentage of net sales — — Reduced loss from operations by 81% vs. Q3 2022 — SAN …

biospace.com

$5
OFF

Evofem Biosciences Announces Financial Results For The Third …

1 week from now

2 days ago · Aditxt, Inc. (Nasdaq: ADTX) has invested $5.0 million in Evofem since May 2024, including $1.3 million from the sale of Series F-1 Preferred Stock to Aditxt in the third quarter …

marketscreener.com

31%
OFF

Evofem Biosciences Announces Financial Results For The Third …

1 week from now

1 day ago · Evofem Biosciences (EVFM) reported Q3 2024 financial results, highlighting a 31% improvement in operating loss to $2.4 million compared to $3.6 million in Q3 2023. Net product …

stocktitan.net

31%
OFF

Evofem Biosciences Announces Financial Results For The Third …

1 week from now

1 day ago · — Improved loss from operations by 31% — — Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health …

sahmcapital.com

FAQs about Evofem Biosciences Announces Financial Results for the Third Coupon?

What did evofem Biosciences announce?

EVOFEM BIOSCIENCES, INC. AND SUBSIDIARIES Evofem Biosciences, Inc. (OTCQB: EVFM) today announced financial results for the third quarter and nine months ended September 30, 2023. Highlights include: ...

Is Evofem Biosciences' market closed or open?

Market is open for Evofem Biosciences, Inc. (Evofem or the Company) (OTCQB: EVFM). The company behind the hormone-free contraceptive Phexxi® (lactic acid, citric acid and potassium bitartrate) today announced financial results for the first quarter of 2024. Highlights of and since the quarter include: ...

Is Evofem Biosciences (EVFM) stock still trending?

Evofem Biosciences (EVFM) stock is still trending after yesterday’s surge. The company has reached an agreement with a leading Pharmacy Benefits Manager (PBM), expanding access to its popular contraceptive Phexxi for millions of women. ...

Does evofem Biosciences Inc (evofem) have a stop-loss?

No stop-loss is set for Evofem Biosciences Inc. (EVFM). For the upcoming trading day on Friday, 19th, we expect the stock to open at $0.0154. The stock is predicted to move between $0.0108 and $0.0200 during the day, which gives a possible trading interval of +/-30.03% (+/-$0.0046) up or down from the last closing price. ...

Does Evofem Biosciences stock have a buy signal?

The Evofem Biosciences stock holds sell signals from both short and long-term moving averages, giving a more negative forecast for the stock. There is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. ...

Does evofem Biosciences stock have a negative forecast?

The Evofem Biosciences stock holds sell signals from both short and long-term moving averages, indicating a more negative forecast for the stock. Some negative signals were issued as well, and these may have some influence on the near short-term development. ...